Bullock Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.7K Buy
110
+1
+0.9% +$371 0.02% 293
2026
Q1
$32.6K Hold
109
– – 0.02% 307
2025
Q4
$38.1K Buy
109
+1
+0.9% +$338 0.02% 289
2025
Q3
$36K Hold
108
– – 0.02% 290
2025
Q2
$42.6K Buy
108
+1
+0.9% +$402 0.02% 257
2025
Q1
$46.3K Hold
107
– – 0.03% 254
2024
Q4
$39.3K Buy
107
+1
+0.9% +$418 0.02% 266
2024
Q3
$54.3K Hold
106
– – 0.03% 235
2024
Q2
$56.6K Sell
106
-40
-27% -$21.1K 0.04% 224
2024
Q1
$75.1K Buy
+146
New +$72.6K 0.05% 206

Other funds holding ELV

Bullock Wealth Management's ELV Position: Q2 2026 in Review

Bullock Wealth Management increased its Elevance Health (ELV) stake by 0.92% in Q2 2026, buying an estimated $371 and bringing the position to 110 shares worth $45.7K. The position accounts for 0.02% of the portfolio, ranked #293.

Bullock Wealth Management first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. The position peaked at $75.1K in Q1 2024. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Bullock Wealth Management held 110 shares of Elevance Health worth $45.7K as of Q2 2026.
  • Bullock Wealth Management bought 1 Elevance Health share in Q2 2026, an estimated $371.
  • Elevance Health made up 0.02% of Bullock Wealth Management's portfolio in Q2 2026, its #293 holding.
  • Bullock Wealth Management first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
  • Bullock Wealth Management's Elevance Health position peaked at $75.1K in Q1 2024.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.